Theralase Technologies Inc.
TLTFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $62,143 | $40,771 | $70,390 | $74,884 |
| - Cash | $269 | $44 | $1,509 | $3,692 |
| + Debt | $294 | $387 | $474 | $36 |
| Enterprise Value | $62,168 | $41,114 | $69,355 | $71,228 |
| Revenue | $1,033 | $1,070 | $1,139 | $781 |
| % Growth | -3.4% | -6% | 45.9% | – |
| Gross Profit | $554 | $562 | $628 | $310 |
| % Margin | 53.6% | 52.5% | 55.2% | 39.7% |
| EBITDA | -$3,960 | -$4,254 | -$4,901 | -$4,130 |
| % Margin | -383.2% | -397.5% | -430.4% | -529% |
| Net Income | -$4,256 | -$4,571 | -$5,235 | -$4,411 |
| % Margin | -411.8% | -427.1% | -459.8% | -565.1% |
| EPS Diluted | -0.018 | -0.021 | -0.025 | -0.022 |
| % Growth | 14.9% | 17.5% | -16.7% | – |
| Operating Cash Flow | -$3,326 | -$4,073 | -$5,103 | -$4,030 |
| Capital Expenditures | -$20 | -$37 | -$70 | -$101 |
| Free Cash Flow | -$3,346 | -$4,110 | -$5,173 | -$4,131 |